Want to see INNV full AI Analyst Report?
INNV Stock Chart & Stats
$10.92
-$0.08(-0.69%)
At close: 4:00 PM EDT
$10.92
-$0.08(-0.69%)
Day’s Range― - ―
52-Week Range$3.94 - $12.64
Previous Close$11.4
Volume236.60K
Average Volume (3M)723.05K
Market Cap
$1.25B
Enterprise Value$1.60B
Total Cash (Recent Filing)$141.33M
Total Debt (Recent Filing)$86.95M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Nov 03, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding136,451,430
10 Day Avg. Volume463,395
30 Day Avg. Volume723,052
Financial Highlights & Ratios
PEG Ratio6.93
Price to Book (P/B)6.83
Price to Sales (P/S)1.62
P/FCF Ratio31.90
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue1.62
Enterprise Value/Gross Profit7.58
Enterprise Value/Ebitda51.30
Forecast
1Y Price Target
$12.00Price Target Upside9.89% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)0.44
Revenue Forecast (FY)$1.08B
Bulls Say, Bears Say
Bulls Say
Participant And Revenue GrowthGrowing participant enrollment expands InnovAge’s recurring capitated revenue base, while the 15.9% revenue increase indicates that census and reimbursement growth are translating into material scale. Management’s fiscal 2027 census and revenue targets support continued expansion over the next several quarters.
Margin And EBITDA ImprovementThe sharp improvement in adjusted EBITDA and center-level contribution margin suggests operating processes and care economics are becoming more efficient. Higher margins create greater capacity to fund technology, participant services and growth, while fiscal 2027 guidance indicates management expects further profitability expansion.
Stronger Balance Sheet And Cash GenerationPositive operating and free cash flow materially strengthen InnovAge’s ability to support center expansion, technology investment and working-capital needs without relying as heavily on external financing. Combined with lower leverage, this provides greater financial flexibility as the company pursues growth opportunities.
Bears Say
Profitability Remains FragileDespite substantial improvement, InnovAge has not yet established consistently positive GAAP earnings or returns on equity. Near-breakeven net income leaves limited room for execution setbacks, and continued investment or operating volatility could delay the conversion of improving EBITDA into durable bottom-line profitability.
Concentrated Reimbursement ExposureA large concentration of participants in California and Colorado makes reimbursement outcomes in those markets especially important to consolidated revenue and care economics. Pending rate decisions and a more tempered fiscal 2027 environment could constrain growth or margin progression if increases do not offset operating costs.
Rising Cost PressuresCost of care increasing faster than the underlying operating base can pressure margins in InnovAge’s capitated model, where reimbursement is largely fixed per member. Higher wages, facility costs and contract expenses may reduce the benefit of enrollment growth unless clinical utilization and internal capabilities continue improving.
InnovAge Holding News
INNV FAQ
What was InnovAge Holding’s price range in the past 12 months?
InnovAge Holding lowest stock price was $3.94 and its highest was $12.64 in the past 12 months.
What is InnovAge Holding’s market cap?
InnovAge Holding’s market cap is $1.25B.
When is InnovAge Holding’s upcoming earnings report date?
InnovAge Holding’s upcoming earnings report date is Nov 03, 2026 which is in 13 days.
How were InnovAge Holding’s earnings last quarter?
InnovAge Holding released its earnings results on Sep 08, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.015.
Is InnovAge Holding overvalued?
According to Wall Street analysts InnovAge Holding’s price is currently Undervalued.
Does InnovAge Holding pay dividends?
InnovAge Holding does not currently pay dividends.
What is InnovAge Holding’s EPS estimate?
InnovAge Holding’s EPS estimate is 0.09.
How many shares outstanding does InnovAge Holding have?
InnovAge Holding has 136,451,430 shares outstanding.
What happened to InnovAge Holding’s price movement after its last earnings report?
InnovAge Holding reported an EPS of $0.06 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went up 4.848%.
Which hedge fund is a major shareholder of InnovAge Holding?
Currently, no hedge funds are holding shares in INNV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InnovAge Holding Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.00 (9.89% Upside)
$12.00 (9.89% Upside)
Blogger Sentiment
Neutral
INNV Sentiment 50%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 64.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $185.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.44%
12-Months-Change
Fundamentals
Return on Equity
-1.05%
Trailing 12-Months
Asset Growth
5.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
InnovAge Holding
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.
INNV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. Management reported substantial improvement in adjusted EBITDA, revenue, census, center-level margins, net loss and de novo losses, supported by operational improvements, lower external provider cost per participant and a stronger balance sheet. The company also provided fiscal 2027 growth and profitability guidance above fiscal 2026 levels and highlighted investments in technology, AI, participant experience and expansion opportunities. Offsetting concerns included one-time legal accruals, higher operating expenses, a sequential decline in quarterly adjusted EBITDA, seasonal third-quarter census softness and a more moderate and still-unfinalized rate environment, particularly in California and Colorado.View all INNV earnings summariesINNV Stock 12 Month Forecast
Average Price Target
$12.00
▲(9.89% Upside)
Technical Analysis
Addus Homecare
―
Astrana Health
―
Agilon Health
―
Aveanna Healthcare Holdings
―
P3 Health Partners
―
Ownership Overview
1.36% Insiders
4.11% Mutual Funds
5.64% Other Institutional Investors
87.04% Public Companies and
Individual Investors